Duopharma names Datuk Wira Arham Abdul Rahman nomination, remuneration committee chairman

• Duopharma Biotech redesignated Datuk Wira Arham bin Abdul Rahman as chairman of its Nomination and Remuneration Committee effective Oct. 1, 2026.
• Arham previously served as a member of the Nomination and Remuneration Committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duopharma Biotech Bhd published the original content used to generate this news brief via Bursa Malaysia (KLSE) (Ref. ID: 3711261) on October 01, 2026, and is solely responsible for the information contained therein.